Evidence map›Paper›PMID 29245298›Full record

ArticleMedicine2017

Metachronous double primary cancer of epithelial and mesenchymal origins: A case report of a rare clinical phenomenon.

Hongzeng Wu, Ze Li, Helin Feng, Jinming Zhang

Abstract read
In one paragraph

Article in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hongzeng WuDepartment of Orthopedics, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, Hebei, PR China Department of Emergency, Hebei Medical University Second Affiliated Hospital, Shijiazhuang, Hebei, PR China.
Ze Li
Helin Feng
Jinming Zhang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleMetachronous double primary cancers from the same origin have previously been reported in several studies; however, the occurrence of double primary cancers from different tissue origins has not been reported earlier. PATIENT CONCERNS: We analyzed 10 patients with requirement surgical treatment. DIAGNOSES: After over 6 months of the surgery, histopathological examination confirmed the presence of at least two neoplastic lesions with distinct histopathology at different locations.

interventionsThese patients underwent surgery and the hematoxylin and eosin staining was performed according to standard protocol in all cases. OUTCOMES: Since the occurrence of multiple primary cancers is an extremely rare event, it is difficult to find a large sample size of patients with double primary cancers at one study center. All patients included in this study received surgical therapy twice and had a final tissue histopathologic diagnosis. LESSONS: Based on our findings, it is concluded that a prolonged follow-up examination for cancer patients should be taken into consideration to provide early detection of secondary tumors and improve overall life expectancy of these patients. Furthermore, clinicians should be well aware of the possibility of cancer patients developing a second primary cancer of a different tissue origin.

Indexed as

AgedAged, 80 and overFemaleHumansMaleMesodermMiddle AgedNeoplasms, Glandular and EpithelialNeoplasms, Second PrimaryRetrospective Studies

Identifiers

PMID29245298
PMCPMC5728913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.